Search Within

Immunology Program Faculty

  1. "2023"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (35)
  3. Review (9)
  4. Editorial (3)
  5. Research Letter (3)
  6. Guidelines (1)
Groups
  1. GSK Faculty (86)
  2. Sloan Kettering Institute Faculty (86)
  3. Department of Medicine (61)
  4. Center for Hematologic Malignancies (54)
  5. Sloan Kettering Institute Postdocs (49)
  6. Hematologic Malignancies, Division of (43)

More Groups

People
  1. Marcel Van Den Brink (36)
  2. Jonathan Peled (18)
  3. Richard O'Reilly (15)
  4. Miguel-Angel Perales (13)
  5. Sergio Giralt (12)
  6. Joseph Sun (11)

More People

Years
  1. 2023 (86)
Publications
  1. Blood (15)
  2. Immunity (6)
  3. Nature Immunology (6)
  4. Journal of Clinical Oncology (5)
  5. Biophysical Journal (4)
  6. Journal of Allergy and Clinical Immunology (4)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Cell Press (15)
  3. Nature Publishing Group (12)
  4. Elsevier Inc. (6)
  5. American Society of Clinical Oncology (5)
  6. Mosby Elsevier (4)

More Publishers

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A dysfunctional program imprinted by Prostaglandin E2 signaling shuts off NK cell communication pathways and disables immunosurveillance of metastasis
    Meeting Abstract

    Pedde, A.; Baumann, T.; Kim, H.; Donakonda, S.; Bayerl, F.; Meiser, P.; Hirschberger, A.; Klement, C.; Grassmann, S.; Öllinger, R.; more...
    European Journal of Immunology (2023)

    Fulltext@MSK | Save
  • Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation
    Meeting Abstract

    Ponce, D. M.; Kosuri, S.; Khera, N.; Defilipp, Z.; Lichter, D. I.; Peled, J. U.; van den Brink, M. R. M.; Brady, K.; Puhl, M. D.; Glick, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CCR1-targeting CAR T cells for acute myeloid leukemia
    Meeting Abstract

    Chen, S.; Boardman, A. P.; James, S. E.; van den Brink, M. R. M.
    Blood (2023)

    Fulltext@MSK | Save
  • Low CD117 expression identifies hematopoietic stem cell subsets with enhanced lymphoid potential in mice and humans
    Meeting Abstract

    Elias, H. K.; Mitra, S.; Gipson, B.; da Silva, M. B.; Lee, N.; Ali, M. A. E.; Grassman, S.; Kousa, A.; DeWolf, S.; Park, C. Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cryopreservation changes the immune effector cell composition of peripheral blood stem cell grafts: An analysis from the DKMS and NMDP graft composition study
    Meeting Abstract

    Rücker-Braun, E.; Falk, B.; Markey, K. A.; Minderman, H.; Baldauf, H.; Heymann, N.; Uhlemann, H.; Heiduschke, L.; MacMillan, H. R.; Newell, E. W.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is common in unrelated stem cell donors but has no impact on patient outcome after hematopoietic stem cell transplantation
    Meeting Abstract

    Schetelig, J.; Damm, F.; Günther, U. P.; Baldauf, H.; Rave, C.; Koster, L.; Schöfl, G.; Klussmeier, A.; Menghrajani, K.; Bolton, K. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bacterial and bacteriophage consortia are associated with protective intestinal immunomodulatory metabolites in allogeneic stem cell transplantation patients
    Meeting Abstract

    Thiele Orberg, E.; Meedt, E.; Hiergeist, A.; Xue, J.; Heinrich, P.; Ghimire, S.; Miltiadous, O.; Lindner, S.; Schwarz, A.; Janssen, K. P.; more...
    Blood (2023)

    Fulltext@MSK | Save